Post by Roche Diagnostics USA
120,180 followers
Today marks a major milestone, with the official launch of the AXELIOS 1 sequencing platform in the U.S. Built to bring a new era to genomics, AXELIOS 1 is now available in the U.S. to help define a new standard in sequencing. Shaped through collaboration with some of the world's leading research centers, this platform combines speed, scalability and flexibility to meet the growing scale and volume demanded by modern research. 1 platform. Endless possibilities. Take the next step and explore the full performance specifications of AXELIOS 1: go.roche.com/AXELIOS_US For Research Use Only. Not for use in diagnostic procedures. AXELIOS is a trademark of Roche.
Video Content